Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
 Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT03153410
40:46:allergy_name,48:58:allergy_name,60:64:treatment,66:74:allergy_name,75:84:allergy_name,86:104:allergy_name,106:113:allergy_name,132:137:allergy_name,151:185:allergy_name
Known or suspected hypersensitivity to GM-CSF, hetastarch, corn, dimethyl sulfoxide, fetal bovine serum, trypsin (porcine origin), yeast or any other component of GVAX pancreas vaccine
2
[ "Known", "or", "suspected", "hypersensitivity", "to", "GM-CSF", ",", "hetastarch", ",", "corn", ",", "dimethyl", "sulfoxide", ",", "fetal", "bovine", "serum", ",", "trypsin", "(", "porcine", "origin", ")", ",", "yeast", "or", "any", "other", "component", "of...
[ 0, 0, 0, 0, 0, 4, 0, 4, 0, 1, 0, 4, 4, 0, 4, 4, 4, 0, 4, 0, 0, 0, 0, 0, 4, 0, 0, 0, 4, 4, 4, 4, 4 ]
NCT02222545
24:35:treatment
Have a positive direct Coombs test
2
[ "Have", "a", "positive", "direct", "Coombs", "test" ]
[ 0, 0, 0, 0, 1, 1 ]
NCT02131467
21:31:allergy_name
Hypersensitivity to perampanel
2
[ "Hypersensitivity", "to", "perampanel" ]
[ 0, 0, 4 ]
NCT02985554
15:39:cancer,47:66:treatment,111:115:chronic_disease,,148:163:chronic_disease
Patients with hematologic malignancies status post allogeneic SCT without evidence of disease relapse, active GVHD or history of more than Stage I skin acute GVHD
2
[ "Patients", "with", "hematologic", "malignancies", "status", "post", "allogeneic", "SCT", "without", "evidence", "of", "disease", "relapse", ",", "active", "GVHD", "or", "history", "of", "more", "than", "Stage", "I", "skin", "acute", "GVHD" ]
[ 0, 0, 3, 3, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2 ]
NCT00881660
46:60:chronic_disease
Suspicion of major recognized syndrome (e.g. Fryns syndrome) on ultrasound or MRI
2
[ "Suspicion", "of", "major", "recognized", "syndrome", "(", "e.g", ".", "Fryns", "syndrome", ")", "on", "ultrasound", "or", "MRI" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0 ]
NCT03115359
1:29:treatment
Cognitive Behavioral Therapy training
2
[ "Cognitive", "Behavioral", "Therapy", "training" ]
[ 1, 1, 1, 0 ]
NCT01760863
17:50:chronic_disease,92:115:treatment,97:115:treatment
Patients with a fungal prosthetic joint infection, unable to tolerate or refuse to undergo oral antibiotic therapy, unable to follow-up at the specified intervals, allergic to the therapy of preference, or have an organism that is not amenable to oral antibiotic therapy
2
[ "Patients", "with", "a", "fungal", "prosthetic", "joint", "infection", ",", "unable", "to", "tolerate", "or", "refuse", "to", "undergo", "oral", "antibiotic", "therapy", ",", "unable", "to", "follow-up", "at", "the", "specified", "intervals", ",", "allergic", ...
[ 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02992275
,,66:84:chronic_disease,
Poorly controlled hypertension (>160/100); or patient report of: symptomatic angina at rest or during exercise, syncope without known resolution of cause, or a significant coronary event (such as a MI) in the past six months
2
[ "Poorly", "controlled", "hypertension", "(", ">", "160/100", ")", ";", "or", "patient", "report", "of", ":", "symptomatic", "angina", "at", "rest", "or", "during", "exercise", ",", "syncope", "without", "known", "resolution", "of", "cause", ",", "or", "a", ...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01685411
,,,58:99:treatment
<45 years of age who are at least 6 months after initial hematopoietic stem cell transplant (HSCT)
2
[ "<", "45", "years", "of", "age", "who", "are", "at", "least", "6", "months", "after", "initial", "hematopoietic", "stem", "cell", "transplant", "(", "HSCT", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0 ]
NCT02796391
22:41:chronic_disease
significant unstable medical/psychiatric or substance use disorders
2
[ "significant", "unstable", "medical/psychiatric", "or", "substance", "use", "disorders" ]
[ 0, 0, 2, 0, 0, 0, 0 ]
NCT01505569
,,61:74:chronic_disease
Cardiac: ejection fraction ≥ 45% or no clinical evidence of heart failure
2
[ "Cardiac", ":", "ejection", "fraction", "≥", "45", "%", "or", "no", "clinical", "evidence", "of", "heart", "failure" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT02433977
1:7:chronic_disease,
Asthma-related ER visit within the previous 4 weeks
2
[ "Asthma-related", "ER", "visit", "within", "the", "previous", "4", "weeks" ]
[ 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT01972919
14:36:chronic_disease
Uncontrolled malabsorption syndrome significantly affecting gastrointestinal function
2
[ "Uncontrolled", "malabsorption", "syndrome", "significantly", "affecting", "gastrointestinal", "function" ]
[ 0, 2, 2, 0, 0, 0, 0 ]
NCT02324608
102:111:allergy_name
History of allergic reactions attributed to compounds of similar chemical or biologic composition to cetuximab or other agents used in the study
2
[ "History", "of", "allergic", "reactions", "attributed", "to", "compounds", "of", "similar", "chemical", "or", "biologic", "composition", "to", "cetuximab", "or", "other", "agents", "used", "in", "the", "study" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0 ]
NCT03110354
32:50:cancer,59:70:cancer,74:82:cancer,96:105:treatment
Has a second concurrent active primary malignancy such as solid tumor or lymphoma under active treatment
2
[ "Has", "a", "second", "concurrent", "active", "primary", "malignancy", "such", "as", "solid", "tumor", "or", "lymphoma", "under", "active", "treatment" ]
[ 0, 0, 0, 0, 0, 3, 3, 0, 0, 3, 3, 0, 3, 0, 0, 1 ]
NCT01827384
15:30:cancer,34:47:chronic_disease,51:87:treatment,89:98:treatment
Patients with bone metastases or hypercalcemia on intravenous bisphosphonate treatment, denosumab, or similar agents
2
[ "Patients", "with", "bone", "metastases", "or", "hypercalcemia", "on", "intravenous", "bisphosphonate", "treatment", ",", "denosumab", ",", "or", "similar", "agents" ]
[ 0, 0, 3, 3, 0, 2, 0, 1, 1, 1, 0, 1, 0, 0, 0, 0 ]
NCT02776891
16:26:treatment
intolerance to gadolinium
2
[ "intolerance", "to", "gadolinium" ]
[ 0, 0, 1 ]
NCT02533882
1:14:chronic_disease
Renal failure
2
[ "Renal", "failure" ]
[ 2, 2 ]
NCT02234557
,28:36:chronic_disease,38:52:chronic_disease,54:76:chronic_disease,78:95:chronic_disease
neurologic disorder (e.g., epilepsy, cerebral palsy, traumatic brain injury, Tourette Syndrome)
2
[ "neurologic", "disorder", "(", "e.g.", ",", "epilepsy", ",", "cerebral", "palsy", ",", "traumatic", "brain", "injury", ",", "Tourette", "Syndrome", ")" ]
[ 0, 0, 0, 0, 0, 2, 0, 2, 2, 0, 2, 2, 2, 0, 2, 2, 0 ]
NCT02593110
1:8:treatment,35:52:treatment,54:80:treatment
Surgery including lower extremity revascularization, coronary revascularization with stenting
2
[ "Surgery", "including", "lower", "extremity", "revascularization", ",", "coronary", "revascularization", "with", "stenting" ]
[ 1, 0, 0, 0, 1, 0, 1, 1, 0, 0 ]
NCT03113760
33:54:treatment
Patients with genetic diagnosis of NLRC4-MAS mutation
2
[ "Patients", "with", "genetic", "diagnosis", "of", "NLRC4-MAS", "mutation" ]
[ 0, 0, 0, 0, 1, 1, 1 ]
NCT02467478
10:24:chronic_disease,28:43:chronic_disease,,131:164:chronic_disease
Previous cardiovascular or cerebrovascular event within 6 months of screening or active or clinically significant coronary and/or Peripheral Vascular Disease (PVD)
2
[ "Previous", "cardiovascular", "or", "cerebrovascular", "event", "within", "6", "months", "of", "screening", "or", "active", "or", "clinically", "significant", "coronary", "and/or", "Peripheral", "Vascular", "Disease", "(", "PVD", ")" ]
[ 0, 2, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0 ]
NCT02068092
1:28:treatment,21:28:treatment,,93:119:treatment
Prior anticoagulant therapy use is allowed provided therapy is discontinued at least 7 days prior to the breast biopsy in order to reduce the risk of bleeding
2
[ "Prior", "anticoagulant", "therapy", "use", "is", "allowed", "provided", "therapy", "is", "discontinued", "at", "least", "7", "days", "prior", "to", "the", "breast", "biopsy", "in", "order", "to", "reduce", "the", "risk", "of", "bleeding" ]
[ 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02172950
,,,61:84:chronic_disease,,
Males 0 to <18 years of who have been diagnosed with severe congenital hemophilia A (FVIII activity levels < 1%)
2
[ "Males", "0", "to", "<", "18", "years", "of", "who", "have", "been", "diagnosed", "with", "severe", "congenital", "hemophilia", "A", "(", "FVIII", "activity", "levels", "<", "1", "%", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02522715
57:78:chronic_disease,80:103:chronic_disease,111:132:chronic_disease
clinical signs suggestive of high or imminent risks for pathological fracture, spinal cord compression and/or cauda equina syndrome
2
[ "clinical", "signs", "suggestive", "of", "high", "or", "imminent", "risks", "for", "pathological", "fracture", ",", "spinal", "cord", "compression", "and/or", "cauda", "equina", "syndrome" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 2, 2, 2, 0, 2, 2, 2 ]
NCT02538198
,,51:64:chronic_disease
New York Heart Association (NYHA) Class III or IV heart failure
2
[ "New", "York", "Heart", "Association", "(", "NYHA", ")", "Class", "III", "or", "IV", "heart", "failure" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT01539109
1:9:chronic_disease
Dementia
2
[ "Dementia" ]
[ 2 ]
NCT02530034
30:38:treatment,42:67:treatment,78:100:cancer
Patients receiving any other standard or investigational treatment for their hematologic malignancy other than supportive care
2
[ "Patients", "receiving", "any", "other", "standard", "or", "investigational", "treatment", "for", "their", "hematologic", "malignancy", "other", "than", "supportive", "care" ]
[ 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 3, 3, 0, 0, 0, 0 ]
NCT02680535
1:15:chronic_disease
mental illness
2
[ "mental", "illness" ]
[ 2, 2 ]
NCT01553071
62:72:cancer,131:139:treatment,143:162:treatment
Patients must have histologically or cytologically confirmed malignancy that is metastatic or unresectable and for which standard curative or palliative measures do not exist or are no longer effective
2
[ "Patients", "must", "have", "histologically", "or", "cytologically", "confirmed", "malignancy", "that", "is", "metastatic", "or", "unresectable", "and", "for", "which", "standard", "curative", "or", "palliative", "measures", "do", "not", "exist", "or", "are", "no"...
[ 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00904046
1:18:treatment,
Thiazolidinedione use in the preceding 18 months
2
[ "Thiazolidinedione", "use", "in", "the", "preceding", "18", "months" ]
[ 1, 0, 0, 0, 0, 0, 0 ]
NCT00713492
25:56:treatment,
Daily or regular use of prescription or OTC medications known to interact with alcohol in the 2-week period prior to assessment
2
[ "Daily", "or", "regular", "use", "of", "prescription", "or", "OTC", "medications", "known", "to", "interact", "with", "alcohol", "in", "the", "2-week", "period", "prior", "to", "assessment" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01742299
74:82:treatment,131:141:treatment,173:192:treatment
Patient has participated in a Novartis sponsored combination trial where imatinib was dispensed in combination with another study medication and patient is still receiving combination therapy
2
[ "Patient", "has", "participated", "in", "a", "Novartis", "sponsored", "combination", "trial", "where", "imatinib", "was", "dispensed", "in", "combination", "with", "another", "study", "medication", "and", "patient", "is", "still", "receiving", "combination", "therap...
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02143726
13:24:treatment
Concomitant medications
2
[ "Concomitant", "medications" ]
[ 0, 1 ]
NCT02169830
15:21:cancer
Patients with cancer
2
[ "Patients", "with", "cancer" ]
[ 0, 0, 3 ]
NCT01505569
74:77:cancer,79:89:cancer,91:101:cancer,103:118:cancer,122:138:cancer,,,,,215:225:cancer
This would require a clinical situation consistent with the diagnosis of GCT (testicular, peritoneal, retroperitoneal or mediastinal mass, elevated tumor marker levels {HCG ≥ 500; AFP ≥ 500} and typical pattern of metastases)
2
[ "This", "would", "require", "a", "clinical", "situation", "consistent", "with", "the", "diagnosis", "of", "GCT", "(", "testicular", ",", "peritoneal", ",", "retroperitoneal", "or", "mediastinal", "mass", ",", "elevated", "tumor", "marker", "levels", "{", "HCG", ...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 3, 0, 3, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0 ]
NCT02379156
1:26:chronic_disease
Untreated thyroid disease
2
[ "Untreated", "thyroid", "disease" ]
[ 2, 2, 2 ]
NCT01306045
36:47:treatment,57:86:treatment,203:232:treatment,,381:424:treatment,479:506:cancer,522:559:treatment,673:682:treatment
The eligibility of patients taking medications that are potent inducers or inhibitors of that enzyme will be determined following a review of their case by the Principal Investigator. (A list of potent CYP3A4 inducers or inhibitors can be found in Appendix F). Every effort should be made to switch patients taking such ...
2
[ "The", "eligibility", "of", "patients", "taking", "medications", "that", "are", "potent", "inducers", "or", "inhibitors", "of", "that", "enzyme", "will", "be", "determined", "following", "a", "review", "of", "their", "case", "by", "the", "Principal", "Investigat...
[ 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0...
NCT02911831
32:43:treatment,45:57:treatment,59:83:treatment,85:95:treatment,97:117:treatment,119:129:treatment,131:146:treatment
Can be previously treated with Depo-Lupron, Depo-Provera, Oral Contraceptive pills, Mirena IUD, endometrial ablation, myomectomy, oral progestins
2
[ "Can", "be", "previously", "treated", "with", "Depo-Lupron", ",", "Depo-Provera", ",", "Oral", "Contraceptive", "pills", ",", "Mirena", "IUD", ",", "endometrial", "ablation", ",", "myomectomy", ",", "oral", "progestins" ]
[ 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 1, 1, 0, 1, 1, 0, 1, 1, 0, 1, 0, 1, 1 ]
NCT01849146
,,53:70:treatment
Pregnant women are excluded from this study because AZD1775 (MK-1775) has potential for teratogenic or abortifacients effects
2
[ "Pregnant", "women", "are", "excluded", "from", "this", "study", "because", "AZD1775", "(", "MK-1775", ")", "has", "potential", "for", "teratogenic", "or", "abortifacients", "effects" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02366871
1:13:chronic_disease
haemophilias
2
[ "haemophilias" ]
[ 2 ]
NCT00959140
1:14:treatment,
chest CT scan within 14 days of registration
2
[ "chest", "CT", "scan", "within", "14", "days", "of", "registration" ]
[ 1, 1, 1, 0, 0, 0, 0, 0 ]
NCT02387216
24:39:chronic_disease
Clinically significant cardiac disease
2
[ "Clinically", "significant", "cardiac", "disease" ]
[ 0, 0, 2, 2 ]
NCT01954576
26:44:cancer,26:29:cancer,70:81:cancer,83:97:cancer,99:113:cancer,115:141:cancer,152:165:cancer,245:261:cancer
Histologically confirmed GBM (WHO grade IV); rare GBM variants (e.g. gliosarcoma, giant cell GBM, small cell GBM, GBM with oligodendroglioma features, GBM with PNET features) are allowed. Patients will be eligible if the original histology was low-grade glioma and a subsequent histological diagnosis of GBM is made
2
[ "Histologically", "confirmed", "GBM", "(", "WHO", "grade", "IV", ")", ";", "rare", "GBM", "variants", "(", "e.g", ".", "gliosarcoma", ",", "giant", "cell", "GBM", ",", "small", "cell", "GBM", ",", "GBM", "with", "oligodendroglioma", "features", ",", "GBM",...
[ 0, 0, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 3, 3, 0, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02507505
9:48:treatment
Planned surgical treatment via hemiarthroplasty
2
[ "Planned", "surgical", "treatment", "via", "hemiarthroplasty" ]
[ 0, 1, 1, 1, 1 ]
NCT02522871
16:28:treatment
Chronic use of hemodialysis
2
[ "Chronic", "use", "of", "hemodialysis" ]
[ 0, 0, 0, 1 ]
NCT02159560
1:9:chronic_disease
Dementia
2
[ "Dementia" ]
[ 2 ]
NCT02565446
29:36:treatment,52:65:chronic_disease,76:104:treatment,112:128:treatment,130:154:treatment,156:190:treatment,196:233:treatment,267:279:treatment
Current or prior history of therapy for underlying liver disease including interferon-based medications, other antiviral agents, immunomodulatory therapy, biologic response modifier therapy, and complementary/alternative medications including (but not encompassing) milk thistle
2
[ "Current", "or", "prior", "history", "of", "therapy", "for", "underlying", "liver", "disease", "including", "interferon-based", "medications", ",", "other", "antiviral", "agents", ",", "immunomodulatory", "therapy", ",", "biologic", "response", "modifier", "therapy", ...
[ 0, 0, 0, 0, 0, 1, 0, 0, 2, 2, 0, 1, 1, 0, 0, 1, 1, 0, 1, 1, 0, 1, 1, 1, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02488967
47:65:cancer,
Definitive clinical or radiologic evidence of metastatic disease; required imaging studies must have been performed within 90 days prior to randomization
2
[ "Definitive", "clinical", "or", "radiologic", "evidence", "of", "metastatic", "disease", ";", "required", "imaging", "studies", "must", "have", "been", "performed", "within", "90", "days", "prior", "to", "randomization" ]
[ 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02133196
38:60:treatment
Patients who are receiving any other investigational agents
2
[ "Patients", "who", "are", "receiving", "any", "other", "investigational", "agents" ]
[ 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02204098
20:49:treatment,74:84:treatment,96:129:treatment,131:148:treatment,153:175:treatment
Current use of any electronic stimulation device, such as cardiac demand pacemakers, automatic implantable cardiac defibrillator, nerve stimulators, or deep brain stimulators
2
[ "Current", "use", "of", "any", "electronic", "stimulation", "device", ",", "such", "as", "cardiac", "demand", "pacemakers", ",", "automatic", "implantable", "cardiac", "defibrillator", ",", "nerve", "stimulators", ",", "or", "deep", "brain", "stimulators" ]
[ 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 1, 0, 1, 1, 0, 0, 1, 1, 1 ]
NCT02985801
8:29:chronic_disease
Common bile duct obstruction resulting in obstructive jaundice
2
[ "Common", "bile", "duct", "obstruction", "resulting", "in", "obstructive", "jaundice" ]
[ 0, 2, 2, 2, 0, 0, 0, 0 ]
NCT02873598
,,82:103:treatment,123:133:treatment,137:148:treatment,153:167:treatment,,
Completion of at least 3 months, but no more than 6 months of standard induction chemotherapy for LAPC, which may include FOLFIRINOX or gemcitabine and nab-paclitaxel, preferably within 2-4 weeks but no longer than 8 weeks
2
[ "Completion", "of", "at", "least", "3", "months", ",", "but", "no", "more", "than", "6", "months", "of", "standard", "induction", "chemotherapy", "for", "LAPC", ",", "which", "may", "include", "FOLFIRINOX", "or", "gemcitabine", "and", "nab-paclitaxel", ",", ...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02188745
15:43:cancer,,,,72:85:cancer,104:115:treatment
Patients with bone-only metastatic disease with a history of ER+/HER2- breast cancer are eligible, and bone biopsy is not required, providing their primary cancer is consistent with the above-described ER and HER2 criteria
2
[ "Patients", "with", "bone-only", "metastatic", "disease", "with", "a", "history", "of", "ER+/HER2-", "breast", "cancer", "are", "eligible", ",", "and", "bone", "biopsy", "is", "not", "required", ",", "providing", "their", "primary", "cancer", "is", "consistent",...
[ 0, 0, 1, 1, 3, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02134392
7:29:chronic_disease,36:60:chronic_disease,62:74:chronic_disease
other chronic pain syndromes (e.g. chronic fatigue syndrome, fibromyalgia)
2
[ "other", "chronic", "pain", "syndromes", "(", "e.g", ".", "chronic", "fatigue", "syndrome", ",", "fibromyalgia", ")" ]
[ 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 2, 0 ]
NCT02530034
28:64:chronic_disease
Patients with known active central nervous system (CNS) disease
2
[ "Patients", "with", "known", "active", "central", "nervous", "system", "(", "CNS", ")", "disease" ]
[ 0, 0, 0, 0, 2, 2, 2, 2, 2, 0, 0 ]
NCT02081404
13:44:chronic_disease,48:57:treatment,63:84:cancer
Presence of columnar lined distal esophagus on endoscopy with intestinal metaplasia
3
[ "Presence", "of", "columnar", "lined", "distal", "esophagus", "on", "endoscopy", "with", "intestinal", "metaplasia" ]
[ 0, 0, 2, 2, 2, 2, 0, 1, 0, 3, 3 ]
NCT02290028
1:17:treatment,37:65:treatment,69:82:treatment,,141:149:treatment,
Cardiac surgical procedure, such as coronary artery bypass graft or valve surgery that is planned to occur within 6 months after implant or ablation that is planned to occur within 90 days after implant
3
[ "Cardiac", "surgical", "procedure", ",", "such", "as", "coronary", "artery", "bypass", "graft", "or", "valve", "surgery", "that", "is", "planned", "to", "occur", "within", "6", "months", "after", "implant", "or", "ablation", "that", "is", "planned", "to", "o...
[ 1, 1, 0, 0, 0, 0, 1, 1, 1, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02527681
39:49:treatment
Sufficient vascular access to receive study drug, and to allow blood sampling at a site separate from the study drug infusion site
3
[ "Sufficient", "vascular", "access", "to", "receive", "study", "drug", ",", "and", "to", "allow", "blood", "sampling", "at", "a", "site", "separate", "from", "the", "study", "drug", "infusion", "site" ]
[ 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02836899
31:72:treatment
Administration of one or more Packed Red Blood Cells (RBCs) transfusion in the week prior to enrollment
3
[ "Administration", "of", "one", "or", "more", "Packed", "Red", "Blood", "Cells", "(", "RBCs", ")", "transfusion", "in", "the", "week", "prior", "to", "enrollment" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00887146
7:14:cancer,57:67:cancer,71:100:cancer,117:122:cancer
mixed gliomas are eligible, regardless of the degree of astrocytic or oligodendrocytic predominance, as long as the tumor is also co-deleted for 1p and 19q
3
[ "mixed", "gliomas", "are", "eligible", ",", "regardless", "of", "the", "degree", "of", "astrocytic", "or", "oligodendrocytic", "predominance", ",", "as", "long", "as", "the", "tumor", "is", "also", "co-deleted", "for", "1p", "and", "19q" ]
[ 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 3, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0 ]
NCT02163317
1:10:treatment,
Bone scan completed within 90 days
3
[ "Bone", "scan", "completed", "within", "90", "days" ]
[ 1, 1, 0, 0, 0, 0 ]
NCT02493530
27:59:treatment
patients with exposure to other JAK-STAT inhibitory agents
3
[ "patients", "with", "exposure", "to", "other", "JAK-STAT", "inhibitory", "agents" ]
[ 0, 0, 0, 0, 1, 1, 1, 1 ]
NCT02272218
1:33:treatment
bilateral total knee replacement
3
[ "bilateral", "total", "knee", "replacement" ]
[ 1, 1, 1, 1 ]
NCT02354703
20:31:chronic_disease
current history of arrhythmias
3
[ "current", "history", "of", "arrhythmias" ]
[ 0, 0, 0, 2 ]
NCT02122172
35:90:treatment,41:68:treatment,94:111:cancer,213:240:treatment,255:269:treatment,273:291:treatment
All patients must have received a prior platinum-based chemotherapy regimen for treatment of urothelial cancer and must now be considered refractory to platinum-based chemotherapy; patients may have received the platinum-containing regimen either in the peri-operative or metastatic setting
3
[ "All", "patients", "must", "have", "received", "a", "prior", "platinum-based", "chemotherapy", "regimen", "for", "treatment", "of", "urothelial", "cancer", "and", "must", "now", "be", "considered", "refractory", "to", "platinum-based", "chemotherapy", ";", "patients...
[ 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 1, 0, 1, 1 ]
NCT02254863
1:19:chronic_disease
Chronic aspiration
3
[ "Chronic", "aspiration" ]
[ 2, 2 ]
NCT02354703
64:71:chronic_disease
Subjects who are deemed by the PI or designee to be at risk of suicide
3
[ "Subjects", "who", "are", "deemed", "by", "the", "PI", "or", "designee", "to", "be", "at", "risk", "of", "suicide" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2 ]
NCT02178566
14:25:chronic_disease
Uncontrolled arrhythmias
3
[ "Uncontrolled", "arrhythmias" ]
[ 0, 2 ]
NCT02841540
31:34:cancer,35:39:cancer,62:91:treatment
Participants with higher-risk MDS/CMML must be intolerant of hypomethylating agents (HMAs)
3
[ "Participants", "with", "higher-risk", "MDS/CMML", "must", "be", "intolerant", "of", "hypomethylating", "agents", "(", "HMAs", ")" ]
[ 0, 0, 0, 3, 0, 0, 0, 0, 1, 1, 1, 0, 0 ]
NCT02050347
49:88:treatment
Patient has an appropriate donor identified for hematopoietic stem cell transplantation
3
[ "Patient", "has", "an", "appropriate", "donor", "identified", "for", "hematopoietic", "stem", "cell", "transplantation" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1 ]
NCT02098161
,,,114:124:treatment,
Sexually active males must use a condom during intercourse while taking the drug and for 3 months after stopping study drug and should not father a child in this period; a condom is required to be used also by vasectomized men in order to prevent delivery of the drug via seminal fluid
3
[ "Sexually", "active", "males", "must", "use", "a", "condom", "during", "intercourse", "while", "taking", "the", "drug", "and", "for", "3", "months", "after", "stopping", "study", "drug", "and", "should", "not", "father", "a", "child", "in", "this", "period",...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01880567
21:24:cancer,,
Relapsed/refractory MCL: Absolute neutrophil count (ANC) >= 500/mm^3
3
[ "Relapsed/refractory", "MCL", ":", "Absolute", "neutrophil", "count", "(", "ANC", ")", ">", "=", "500/mm^3" ]
[ 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02400255
20:54:chronic_disease,63:80:chronic_disease,84:110:chronic_disease
Known positive for human immunodeficiency virus (HIV); active hepatitis B (HBV) or hepatitis C (HCV) infection
3
[ "Known", "positive", "for", "human", "immunodeficiency", "virus", "(", "HIV", ")", ";", "active", "hepatitis", "B", "(", "HBV", ")", "or", "hepatitis", "C", "(", "HCV", ")", "infection" ]
[ 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02479906
38:50:chronic_disease
Subject has a history of significant hearing loss
3
[ "Subject", "has", "a", "history", "of", "significant", "hearing", "loss" ]
[ 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT01553071
,,,118:128:treatment
For women of child-bearing potential, a negative serum pregnancy test is required within 72 hours prior to receiving study drug each cycle
3
[ "For", "women", "of", "child-bearing", "potential", ",", "a", "negative", "serum", "pregnancy", "test", "is", "required", "within", "72", "hours", "prior", "to", "receiving", "study", "drug", "each", "cycle" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0 ]
NCT02341300
24:30:chronic_disease,64:81:chronic_disease,83:102:chronic_disease,104:115:chronic_disease,117:124:chronic_disease
Any secondary cause of anemia including inherited and acquired hemolytic anemias (sickle cell disease, thalessemia, malaria, etc) Inability or unwillingness to try to use cast iron pot approximately 3x/week
3
[ "Any", "secondary", "cause", "of", "anemia", "including", "inherited", "and", "acquired", "hemolytic", "anemias", "(", "sickle", "cell", "disease", ",", "thalessemia", ",", "malaria", ",", "etc", ")", "Inability", "or", "unwillingness", "to", "try", "to", "use...
[ 0, 0, 0, 0, 2, 0, 0, 0, 0, 2, 2, 0, 2, 2, 2, 0, 2, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02875301
1:7:chronic_disease
angina
3
[ "angina" ]
[ 2 ]
NCT01913106
1:7:treatment,35:50:cancer,59:77:cancer,88:103:treatment,,155:172:treatment
biopsy-proven local recurrence of prostate cancer without metastatic disease after the hormone therapy at least 2 year after the completion of definitive radiation therapy
3
[ "biopsy-proven", "local", "recurrence", "of", "prostate", "cancer", "without", "metastatic", "disease", "after", "the", "hormone", "therapy", "at", "least", "2", "year", "after", "the", "completion", "of", "definitive", "radiation", "therapy" ]
[ 1, 0, 0, 0, 3, 3, 0, 3, 3, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02512718
10:27:chronic_disease
Unstable diabetes mellitus
3
[ "Unstable", "diabetes", "mellitus" ]
[ 0, 2, 2 ]
NCT02952365
15:36:chronic_disease
Subjects with ectatic eye disorders
3
[ "Subjects", "with", "ectatic", "eye", "disorders" ]
[ 0, 0, 2, 2, 2 ]
NCT01794793
87:103:treatment
Written informed consent obtained prior to enrolling in roll-over study and receiving study medication
3
[ "Written", "informed", "consent", "obtained", "prior", "to", "enrolling", "in", "roll-over", "study", "and", "receiving", "study", "medication" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0 ]
NCT03145298
19:26:chronic_disease
All patients with PAH-HIV must be on a stable and effective HAART combination regimen
3
[ "All", "patients", "with", "PAH-HIV", "must", "be", "on", "a", "stable", "and", "effective", "HAART", "combination", "regimen" ]
[ 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02148796
51:55:chronic_disease
Participants may not have had more than two prior WLRI episodes
3
[ "Participants", "may", "not", "have", "had", "more", "than", "two", "prior", "WLRI", "episodes" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0 ]
NCT02429830
,19:32:chronic_disease,50:59:treatment,63:80:treatment
Presence of ˃3 cm hiatal hernia as determined by endoscopy or barium esophagram
3
[ "Presence", "of", "˃3", "cm", "hiatal", "hernia", "as", "determined", "by", "endoscopy", "or", "barium", "esophagram" ]
[ 0, 0, 0, 0, 2, 2, 0, 0, 0, 1, 0, 1, 1 ]
NCT02542202
1:16:chronic_disease,24:48:chronic_disease,59:74:treatment,
Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months prior to registration
3
[ "Unstable", "angina", "and/or", "congestive", "heart", "failure", "requiring", "hospitalization", "within", "the", "last", "6", "months", "prior", "to", "registration" ]
[ 2, 2, 0, 2, 2, 2, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01947673
1:22:chronic_disease
autonomic dysfunction
3
[ "autonomic", "dysfunction" ]
[ 2, 2 ]
NCT01697293
1:13:chronic_disease,21:52:cancer,70:90:treatment,109:118:treatment,122:135:cancer
osteoporosis, prior ductal carcinoma in situ [DCIS]), or who receive aromatase inhibitors for prevention or treatment of breast cancer, are eligible
3
[ "osteoporosis", ",", "prior", "ductal", "carcinoma", "in", "situ", "[", "DCIS", "]", ")", ",", "or", "who", "receive", "aromatase", "inhibitors", "for", "prevention", "or", "treatment", "of", "breast", "cancer", ",", "are", "eligible" ]
[ 2, 0, 0, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 1, 0, 3, 3, 0, 0, 0 ]
NCT02291523
,,35:53:chronic_disease
7-21 who have been diagnosed with ulcerative colitis
3
[ "7-21", "who", "have", "been", "diagnosed", "with", "ulcerative", "colitis" ]
[ 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT01811368
13:28:chronic_disease
Symptomatic biliary disease
3
[ "Symptomatic", "biliary", "disease" ]
[ 0, 2, 2 ]
NCT02633111
24:48:treatment,63:68:treatment,84:90:treatment,92:102:treatment
Recipient of frontline multi-agent chemotherapy (for example, RCHOP, dose adjusted-REPOCH, RCHOP/RICE, RCHOP+investigational agent, etc)
3
[ "Recipient", "of", "frontline", "multi-agent", "chemotherapy", "(", "for", "example", ",", "RCHOP", ",", "dose", "adjusted-REPOCH", ",", "RCHOP/RICE", ",", "RCHOP+investigational", "agent", ",", "etc", ")" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0 ]
NCT00492778
15:35:chronic_disease,49:54:treatment,58:84:treatment
Patients with ureteral obstruction must undergo stent or nephrostomy tube placement prior to study entry
3
[ "Patients", "with", "ureteral", "obstruction", "must", "undergo", "stent", "or", "nephrostomy", "tube", "placement", "prior", "to", "study", "entry" ]
[ 0, 0, 2, 2, 0, 0, 1, 0, 1, 1, 1, 0, 0, 0, 0 ]
NCT02293096
21:31:allergy_name
hypersensitivity to metoprolol or its derivatives
3
[ "hypersensitivity", "to", "metoprolol", "or", "its", "derivatives" ]
[ 0, 0, 4, 0, 0, 0 ]
NCT00904046
13:24:chronic_disease
significant pedal edema
3
[ "significant", "pedal", "edema" ]
[ 0, 2, 2 ]
NCT02076906
1:14:treatment
pegfilgrastim
3
[ "pegfilgrastim" ]
[ 1 ]
NCT02101944
1:16:treatment,7:16:treatment,,99:122:treatment,
Prior radiation is permitted; however, at least 2 weeks must have elapsed since the completion of prior radiation therapy and patients must have recovered from all radiation-associated toxicities to no greater than grade 1 at the time of registration
3
[ "Prior", "radiation", "is", "permitted", ";", "however", ",", "at", "least", "2", "weeks", "must", "have", "elapsed", "since", "the", "completion", "of", "prior", "radiation", "therapy", "and", "patients", "must", "have", "recovered", "from", "all", "radiation...
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02633891
1:21:chronic_disease
Autonomic neuropathy as defined by the Toronto Diabetic Neuropathy Expert Group 2010/11 consensus criteria
3
[ "Autonomic", "neuropathy", "as", "defined", "by", "the", "Toronto", "Diabetic", "Neuropathy", "Expert", "Group", "2010/11", "consensus", "criteria" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02131467
1:21:treatment
Cognitive impairment
3
[ "Cognitive", "impairment" ]
[ 1, 1 ]
NCT02138617
13:31:chronic_disease,47:59:chronic_disease,79:106:treatment
Evidence of bleeding diathesis or significant coagulopathy (in the absence of therapeutic anticoagulation)
3
[ "Evidence", "of", "bleeding", "diathesis", "or", "significant", "coagulopathy", "(", "in", "the", "absence", "of", "therapeutic", "anticoagulation", ")" ]
[ 0, 0, 2, 2, 0, 0, 2, 0, 0, 0, 0, 0, 1, 1, 0 ]
NCT02056873
26:33:chronic_disease,
Any attempt or intent of suicide in the last 6 months
3
[ "Any", "attempt", "or", "intent", "of", "suicide", "in", "the", "last", "6", "months" ]
[ 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0 ]